Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / June / Mapping Cancer Through Cell Surface Sugars
Oncology Biochemistry and molecular biology Microscopy and imaging Research and Innovations

Mapping Cancer Through Cell Surface Sugars

New imaging approach identifies distinct glycan signatures in tumors, immune cells, and healthy tissue

06/01/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions

Share

Researchers have developed a microscopy-based method that maps the organization of glycans – sugar molecules found on the cell surface – at nanometer-scale resolution and links those patterns to cellular behavior and disease state. The approach, called “glycan atlassing,” was reported in Nature Nanotechnology.

The glycocalyx, the sugar-rich coating that surrounds cells, plays an important role in immune signaling, cell adhesion, inflammation, and cancer biology. Changes in glycosylation are well recognized in tumors and immune activation, but studying how these molecules are spatially organized on cells has been technically difficult. Conventional microscopy lacks sufficient resolution, while methods such as mass spectrometry do not preserve spatial relationships within tissues.

In this study, investigators combined DNA-tagged lectins, metabolic glycan labeling, and super-resolution microscopy to create detailed maps of glycan distribution on cells and tissues. They then used computational analysis to identify recurring glycan patterns associated with specific cellular states.

The researchers tested the method in cultured epithelial cells, primary neurons, human immune cells, and human breast cancer tissue. Across these systems, the technique was able to distinguish different biologic conditions based on glycan organization alone.

In breast epithelial cell models, glycan patterns differed between normal and transformed cells and also changed during epithelial-to-mesenchymal transition, a process associated with cancer progression.

In immune cells, the method detected rapid changes in the glycocalyx after activation. Natural killer cells exposed to lung cancer cells showed measurable glycan reorganization within minutes, suggesting that immune cell surface architecture changes dynamically during immune responses. Activated CD4-positive T cells and neutrophils also displayed distinct glycan signatures compared with resting cells.

The technique was also applied to human breast adenocarcinoma tissue sections. Tumor and non-tumor regions demonstrated different glycan organization patterns, and tumor tissue showed greater heterogeneity.

Although the approach is currently research-focused and technically complex, the findings highlight the potential diagnostic relevance of glycocalyx architecture. The authors suggest that nanoscale glycan patterns may eventually help classify tumors, characterize immune activation states, or provide additional biologic information beyond conventional histology and molecular testing.

The investigators also noted current limitations, including the need for specialized imaging equipment, labor-intensive analysis, and a limited number of glycan targets.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Intense Intestines
Microscopy and imaging
Intense Intestines

January 19, 2024

1 min read

Some powerful fluorescent microscopy in this Image of the Month…

Context Matters in Cancer Biology
Microscopy and imaging
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

When Pathology Goes 3D
Microscopy and imaging
When Pathology Goes 3D

February 2, 2022

1 min read

Stratifying cancers with non-destructive 3D pathology

Sacrificing Safety for Speed?
Microscopy and imaging
Sacrificing Safety for Speed?

February 4, 2022

3 min read

Wide adaptation of antigen testing could increase the risk of exposure to infectious SARS-CoV-2 samples

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.